1. Home
  2. MYGN vs PWRL Comparison

MYGN vs PWRL Comparison

Compare MYGN & PWRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$5.44

Market Cap

523.7M

Sector

Health Care

ML Signal

N/A

PWRL

Powerlaw Corp. Common Stock

N/A

Current Price

$9.99

Market Cap

513.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MYGN
PWRL
Founded
1991
N/A
Country
United States
United States
Employees
2700
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
523.7M
513.6M
IPO Year
1996
2025

Fundamental Metrics

Financial Performance
Metric
MYGN
PWRL
Price
$5.44
$9.99
Analyst Decision
Hold
Analyst Count
9
0
Target Price
★ $5.90
N/A
AVG Volume (30 Days)
★ 1.7M
124.3K
Earning Date
11-04-2026
N/A
Dividend Yield
N/A
★ 2.35%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $771,400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 2.33
N/A
52 Week Low
$2.74
$9.41
52 Week High
$8.09
$16.31

Technical Indicators

Market Signals
Indicator
MYGN
PWRL
Relative Strength Index (RSI) 46.99 34.56
Support Level $4.19 $9.41
Resistance Level $5.52 $12.54
Average True Range (ATR) 0.30 0.59
MACD -0.13 -0.13
Stochastic Oscillator 0.00 18.65

Price Performance

Historical Comparison
MYGN
PWRL

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About PWRL Powerlaw Corp. Common Stock

Powerlaw Corp is a non-diversified, closed-end management investment company. The Fund's investment objective is long-term capital appreciation. It seeks to achieve its investment objective by investing in the equity and equity-linked securities of a concentrated portfolio of approximately 12 to 15 late-stage technology companies.

Share on Social Networks: